iDNA Genomics Public Ltd. specializes in the field of genomics and biotechnology, and personalized health care. It was formed for the purpose of development and provision of genetic testing in the field of genomics, through professional medical genomics and direct-to-consumer genomics. The company was founded on November 16, 2020 and is headquartered in Nicosia, Cyprus.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company